Sort   by:  
 Page size 
UnknownMechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
Not available
S-EPMC4773169 | biostudies-literature
UnknownStructural determinants for activity and specificity of the bacterial toxin LlpA.
Not available
S-EPMC3585409 | biostudies-literature
UnknownStructure-function elucidation of a new α-conotoxin, Lo1a, from Conus longurionis.
Not available
S-EPMC3975008 | biostudies-literature
UnknownTelomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients.
Not available
S-EPMC9598704 | biostudies-literature
UnknownEndemic Kaposi's Sarcoma.
Not available
S-EPMC9913747 | biostudies-literature
UnknownRICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy.
Not available
S-EPMC8533235 | biostudies-literature
UnknownNovel Conopeptides of Largely Unexplored Indo Pacific Conus sp.
Not available
S-EPMC5128742 | biostudies-literature
UnknownHealth-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Not available
S-EPMC5636622 | biostudies-literature
UnknownDabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Not available
S-EPMC5991615 | biostudies-literature
UnknownOverall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Not available
S-EPMC4108862 | biostudies-literature
Sort   by:  
 Page size